Back to Search Start Over

Dupilumab Reduced Oral Corticosteroid (OCS) Use in Patients with OCS-Dependent, Severe Asthma Consistently Across Baseline Demographic Characteristics in the Phase 3 LIBERTY ASTHMA VENTURE Study

Authors :
N. Daizadeh
Benjamin Ortiz
N. Pandit-Abid
L.B. Ford
J.F. Maspero
Yamo Deniz
P. Rowe
Source :
B101. NEW BIOLOGICAL TREATMENTS FOR ASTHMA.
Publication Year :
2020
Publisher :
American Thoracic Society, 2020.

Subjects

Subjects :
medicine.medical_specialty
medicine.drug_class
business.industry
Internal medicine
Severe asthma
medicine
Corticosteroid
In patient
medicine.disease
Baseline (configuration management)
business
Dupilumab
Asthma

Details

Database :
OpenAIRE
Journal :
B101. NEW BIOLOGICAL TREATMENTS FOR ASTHMA
Accession number :
edsair.doi...........f328f7f0b8683aca9ebc0848050dbf7f
Full Text :
https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4260
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details